Ticker Launch
Sign inTry it free

IPO · DAWN

Day One Biopharmaceuticals, Inc.

Formerly Day One Biopharmaceuticals Holding Co LLC

Day One Biopharmaceuticals, Inc. (DAWN) priced its initial public offering on May 27, 2021 at $16.00 per share, within its $14.00–$16.00 range, raising $160M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $966.9M. J.P. Morgan was lead-left underwriter, joined by TD Cowen, Piper Sandler and Wedbush. Fenwick & West advised the company and Cooley advised the underwriters.

Status
IPO
Ticker
DAWN
Exchange
Nasdaq Global Select
Priced
May 27, 2021
IPO price
$16.00
Price range
$14.00–$16.00
Raised
$160M
Market cap at IPO price
$966.9M
First filed
May 4, 2021
Underwriters
J.P. Morgan, TD Cowen, Piper Sandler and Wedbush
Company counsel
Fenwick & West
Underwriters' counsel
Cooley
Sector
Biotech & pharma
Country / state
CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other Biotech & pharma IPOs in 2021